Neoadjuvant Immunotherapy Plus Chemotherapy for Resectable Stage IIIA Non-Small Cell Lung Cancer

Condition:   IIIA Stage Non-small Cell Lung Cancer Intervention:   Drug: Sintilimab Injection Sponsor:   First Hospital of Jilin University Recruiting

Source: ClinicalTrials.gov - March 30, 2020 Category: Research Source Type: clinical trials